Vor Biopharma Statistics

Total Valuation

Vor Biopharma has a market cap or net worth of $63.02 million. The enterprise value is -$12.13 million.

Market Cap	63.02M
Enterprise Value	-12.13M

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, after market close.

Earnings Date	Aug 8, 2024
Ex-Dividend Date	n/a

Share Statistics

Vor Biopharma has 68.26 million shares outstanding. The number of shares has increased by 2.66% in one year.

Shares Outstanding	68.26M
Shares Change (YoY)	+2.66%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	1.20%
Owned by Institutions (%)	87.55%
Float	31.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.51
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.46, with a Debt / Equity ratio of 0.28.

Current Ratio	8.46
Quick Ratio	n/a
Debt / Equity	0.28
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -73.70% and return on invested capital (ROIC) is -81.09%.

Return on Equity (ROE)	-73.70%
Return on Assets (ROA)	-57.30%
Return on Capital (ROIC)	-81.09%
Revenue Per Employee	n/a
Profits Per Employee	-$715,679
Employee Count	168
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.41% in the last 52 weeks. The beta is -0.34, so Vor Biopharma's price volatility has been lower than the market average.

Beta (5Y)	-0.34
52-Week Price Change	-71.41%
50-Day Moving Average	1.29
200-Day Moving Average	1.89
Relative Strength Index (RSI)	33.02
Average Volume (20 Days)	545,761

Short Selling Information

The latest short interest is 2.83 million, so 4.14% of the outstanding shares have been sold short.

Short Interest	2.83M
Short Previous Month	3.80M
Short % of Shares Out	4.14%
Short % of Float	8.86%
Short Ratio (days to cover)	5.42

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-127.94M
Pretax Income	-120.23M
Net Income	-120.23M
EBITDA	-112.63M
EBIT	-120.23M
Earnings Per Share (EPS)	-$1.77

Full Income Statement

Balance Sheet

The company has $109.89 million in cash and $34.74 million in debt, giving a net cash position of $75.15 million or $1.10 per share.

Cash & Cash Equivalents	109.89M
Total Debt	34.74M
Net Cash	75.15M
Net Cash Per Share	$1.10
Equity (Book Value)	123.04M
Book Value Per Share	1.80
Working Capital	98.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$106.49 million and capital expenditures -$1.09 million, giving a free cash flow of -$107.58 million.

Operating Cash Flow	-106.49M
Capital Expenditures	-1.09M
Free Cash Flow	-107.58M
FCF Per Share	-$1.58

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Vor Biopharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.66%
Shareholder Yield	-2.66%
Earnings Yield	-190.77%
FCF Yield	-170.69%

Analyst Forecast

The average price target for Vor Biopharma is $12.50, which is 1,253.84% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.50
Price Target Difference	1,253.84%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-21.00%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2